Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

TRoMbone is a feasibility study, with embedded Qualitative Recruitment Investigation (QRI), looking at whether patients can be recruited into a trial that compares standard care for treating oligo-metastatic prostate cancer verses the addition of radical prostatectomy to standard care.

We are delighted to announce that with the hard work of everyone involved with TRoMbone, especially the participating sites, we achieved our target of 50 patients (51 at the last randomisation) on 18th April 2018! Congratulations!